ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer

Shruti Jolly, Payal Soni, David K. Gaffney, Matthew Biagioli, Mohamed A. Elshaikh, Anuja Jhingran, Elizabeth Kidd, Larissa J. Lee, Linna Li, David H. Moore, Gautam G. Rao, Andrew O. Wahl, Ned L. Williams, Catheryn M. Yashar, William Small

Research output: Contribution to journalArticle

Abstract

These American College of Radiology consensus guidelines were formed from an expert panel on the appropriate use of adjuvant therapy in vulvar cancer after primary treatment with surgery. The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel reviewed the pertinent literature in vulvar cancer and voted on three variants to establish appropriate use of imaging, adjuvant radiation, including dose, fields, and technique, as well as adjuvant chemotherapy. This report will aid clinicians in selecting appropriate patients for adjuvant treatment and will provide guidelines for the optimal delivery of adjuvant radiation therapy and chemotherapy.

Original languageEnglish (US)
JournalOncology (Williston Park, N.Y.)
Volume29
Issue number11
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

Vulvar Neoplasms
Guidelines
Radiology
Therapeutics
Expert Testimony
Adjuvant Chemotherapy
Radiotherapy
Radiation
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jolly, S., Soni, P., Gaffney, D. K., Biagioli, M., Elshaikh, M. A., Jhingran, A., ... Small, W. (2015). ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park, N.Y.), 29(11).

ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer. / Jolly, Shruti; Soni, Payal; Gaffney, David K.; Biagioli, Matthew; Elshaikh, Mohamed A.; Jhingran, Anuja; Kidd, Elizabeth; Lee, Larissa J.; Li, Linna; Moore, David H.; Rao, Gautam G.; Wahl, Andrew O.; Williams, Ned L.; Yashar, Catheryn M.; Small, William.

In: Oncology (Williston Park, N.Y.), Vol. 29, No. 11, 01.11.2015.

Research output: Contribution to journalArticle

Jolly, S, Soni, P, Gaffney, DK, Biagioli, M, Elshaikh, MA, Jhingran, A, Kidd, E, Lee, LJ, Li, L, Moore, DH, Rao, GG, Wahl, AO, Williams, NL, Yashar, CM & Small, W 2015, 'ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer', Oncology (Williston Park, N.Y.), vol. 29, no. 11.
Jolly S, Soni P, Gaffney DK, Biagioli M, Elshaikh MA, Jhingran A et al. ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer. Oncology (Williston Park, N.Y.). 2015 Nov 1;29(11).
Jolly, Shruti ; Soni, Payal ; Gaffney, David K. ; Biagioli, Matthew ; Elshaikh, Mohamed A. ; Jhingran, Anuja ; Kidd, Elizabeth ; Lee, Larissa J. ; Li, Linna ; Moore, David H. ; Rao, Gautam G. ; Wahl, Andrew O. ; Williams, Ned L. ; Yashar, Catheryn M. ; Small, William. / ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer. In: Oncology (Williston Park, N.Y.). 2015 ; Vol. 29, No. 11.
@article{e2968e99ea5e4242926993d8c30a9724,
title = "ACR Appropriateness Criteria{\circledR} Adjuvant Therapy in Vulvar Cancer",
abstract = "These American College of Radiology consensus guidelines were formed from an expert panel on the appropriate use of adjuvant therapy in vulvar cancer after primary treatment with surgery. The American College of Radiology Appropriateness Criteria{\circledR} are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel reviewed the pertinent literature in vulvar cancer and voted on three variants to establish appropriate use of imaging, adjuvant radiation, including dose, fields, and technique, as well as adjuvant chemotherapy. This report will aid clinicians in selecting appropriate patients for adjuvant treatment and will provide guidelines for the optimal delivery of adjuvant radiation therapy and chemotherapy.",
author = "Shruti Jolly and Payal Soni and Gaffney, {David K.} and Matthew Biagioli and Elshaikh, {Mohamed A.} and Anuja Jhingran and Elizabeth Kidd and Lee, {Larissa J.} and Linna Li and Moore, {David H.} and Rao, {Gautam G.} and Wahl, {Andrew O.} and Williams, {Ned L.} and Yashar, {Catheryn M.} and William Small",
year = "2015",
month = "11",
day = "1",
language = "English (US)",
volume = "29",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "11",

}

TY - JOUR

T1 - ACR Appropriateness Criteria® Adjuvant Therapy in Vulvar Cancer

AU - Jolly, Shruti

AU - Soni, Payal

AU - Gaffney, David K.

AU - Biagioli, Matthew

AU - Elshaikh, Mohamed A.

AU - Jhingran, Anuja

AU - Kidd, Elizabeth

AU - Lee, Larissa J.

AU - Li, Linna

AU - Moore, David H.

AU - Rao, Gautam G.

AU - Wahl, Andrew O.

AU - Williams, Ned L.

AU - Yashar, Catheryn M.

AU - Small, William

PY - 2015/11/1

Y1 - 2015/11/1

N2 - These American College of Radiology consensus guidelines were formed from an expert panel on the appropriate use of adjuvant therapy in vulvar cancer after primary treatment with surgery. The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel reviewed the pertinent literature in vulvar cancer and voted on three variants to establish appropriate use of imaging, adjuvant radiation, including dose, fields, and technique, as well as adjuvant chemotherapy. This report will aid clinicians in selecting appropriate patients for adjuvant treatment and will provide guidelines for the optimal delivery of adjuvant radiation therapy and chemotherapy.

AB - These American College of Radiology consensus guidelines were formed from an expert panel on the appropriate use of adjuvant therapy in vulvar cancer after primary treatment with surgery. The American College of Radiology Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. The panel reviewed the pertinent literature in vulvar cancer and voted on three variants to establish appropriate use of imaging, adjuvant radiation, including dose, fields, and technique, as well as adjuvant chemotherapy. This report will aid clinicians in selecting appropriate patients for adjuvant treatment and will provide guidelines for the optimal delivery of adjuvant radiation therapy and chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84953848501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953848501&partnerID=8YFLogxK

M3 - Article

C2 - 26568534

VL - 29

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 11

ER -